This is in contrast to the observed profile of CCAT1 and cMYC that seem to be overexpressed in the majority of samples in any of the three stages of colorectal adenoma, advanced adenoma, and adenocarcinoma. The gene discussed is MYC; the disease is colorectal adenoma.